Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cerebrospinal Fluid01:21

Cerebrospinal Fluid

3.3K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic Approaches for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: Current and Emerging Strategies.

Pathogens (Basel, Switzerland)·2026
Same author

Seed Amplification Assays for Parkinson's Disease: A Review of α-Synuclein Assays in Body Fluids and Tissues.

Journal of neurochemistry·2026
Same author

ATNIVS biomarker heterogeneity in real-world patients receiving lecanemab.

The journal of prevention of Alzheimer's disease·2026
Same author

Early onset Alzheimer's disease with V180I variant of prion protein gene and a family history of dementia: a case report.

BMC neurology·2026
Same author

A noninvasive test for human prion disease using hair roots and scalp.

Scientific reports·2025
Same author

Repeated artificial mutagenesis of Bradyrhizobium diazoefficiens by gamma irradiation accelerates the acquisition of high-temperature tolerance.

Mutation research·2025

Related Experiment Video

Updated: Oct 3, 2025

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

64.0K

CSF biomarkers for prion diseases.

Katsuya Satoh1

  • 1Department of Health Sciences, Unit of Medical and Dental Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan; Department of Brain Research Unite, Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Japan.

Neurochemistry International
|February 17, 2022
PubMed
Summary

Accurate diagnosis of human prion diseases (HPD) is crucial for early treatment. Cerebrospinal fluid (CSF) biomarkers, especially real-time quaking-induced conversion (RT-QuIC), show high sensitivity and specificity for HPD detection.

Keywords:
BiomarkerCSFPrP(Sc)-seeded aggregation assayPrion diseaseRT-QuIC assayTherapeutic window

More Related Videos

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

11.1K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Related Experiment Videos

Last Updated: Oct 3, 2025

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
06:40

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice

Published on: March 19, 2018

64.0K
Quantitative Measurement of Intrathecally Synthesized Proteins in Mice
08:23

Quantitative Measurement of Intrathecally Synthesized Proteins in Mice

Published on: November 29, 2019

11.1K
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

Area of Science:

  • Neurology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Early diagnosis of human prion diseases (HPD) is critical for effective treatment, yet few studies focus on early-stage biomarkers.
  • Current diagnostic criteria (WHO, UK, European) combine clinical findings, CSF markers (14-3-3, total tau), EEG, and MRI-DWI.
  • Advancements in MRI-DWI and lab testing improve prion disease diagnostics, but misdiagnosis can occur due to similar brain imaging findings in other rapidly progressing dementias.

Purpose of the Study:

  • To highlight the critical role of cerebrospinal fluid (CSF) biomarkers in accurately diagnosing human prion diseases.
  • To review current and emerging methods for CSF biomarker analysis in HPD.
  • To emphasize the diagnostic utility of protein amplification methods, particularly RT-QuIC.

Main Methods:

  • Review of diagnostic criteria for HPD, including WHO, UK, and European guidelines.
  • Discussion of CSF biomarker investigation approaches: biochemical assays and protein amplification methods.
  • Focus on the protein misfolding cyclic amplification (PMCA) assay and real-time quaking-induced conversion (RT-QuIC) assay.

Main Results:

  • CSF biomarkers are essential for accurate HPD diagnosis, differentiating it from other neurological conditions.
  • Protein amplification methods, like RT-QuIC, leverage prion protein (PrPSc) properties for sensitive detection.
  • RT-QuIC analysis of CSF demonstrates high sensitivity and specificity for sporadic HPD forms.

Conclusions:

  • Accurate diagnosis of HPD relies heavily on CSF biomarker analysis.
  • RT-QuIC is a highly sensitive and specific diagnostic tool for sporadic HPD and is now part of diagnostic criteria.
  • Further research into early-stage biomarkers is needed to optimize therapeutic windows for HPD treatments.